Borchmann, Peter

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Schuster, S. J., Bishop, M. R., Tam, C. S., Waller, E. K., Borchmann, P., McGuirk, J. P., Jäger, U., Jaglowski, S., Andreadis, C., Westin, J. R., et al. (2019) · New England Journal of Medicine

CAR-T cell therapy researchLymphoma Diagnosis and Treatment

Cited by 4,112

Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma

Mettler, J., Müller, H., Voltin, C.-A., Baues, C., Klaeser, B., Moccia, A., Borchmann, P., Engert, A., Kuhnert, G., Drzezga, A., et al. (2019) · Journal of Nuclear Medicine

Lymphoma Diagnosis and TreatmentMedical Imaging Techniques and Applications

Cited by 89

LBA38 BNT211-01: A Phase I Trial to Evaluate Safety and Efficacy of CLDN6 CAR T Cells and CLDN6-Encoding MRNA Vaccine-Mediated in Vivo Expansion in Patients with CLDN6-Positive Advanced Solid Tumours

Mackensen, A., Haanen, J. B. A. G., Koenecke, C., Alsdorf, W., Wagner-Drouet, E., Heudobler, D., Borchmann, P., Bokemeyer, C., Klobuch, S., Smit, E., et al. (2022) · Annals of Oncology

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 25

Moving the goalposts while scoring―the dilemma posed by new PET technologies

Rogasch, J. M. M., Boellaard, R., Pike, L., Borchmann, P., Johnson, P., Wolf, J., Barrington, S. F., & Kobe, C. (2021) · European Journal of Nuclear Medicine and Molecular Imaging

Medical Imaging Techniques and ApplicationsCardiac Imaging and Diagnostics

Cited by 20

Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma

Aleksandrova, K., Leise, J., Priesner, C., Aktas, M., Apel, M., Assenmacher, M., Bürger, I., Richter, A., Altefrohne, P., Schubert, C., et al. (2024) · Frontiers in Immunology

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 15

Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?

Voltin, C.-A., Mettler, J., Boellaard, R., Kuhnert, G., Dietlein, M., Borchmann, P., Drzezga, A., & Kobe, C. (2019) · Nuclear Medicine Communications

Medical Imaging Techniques and ApplicationsLymphoma Diagnosis and Treatment

Cited by 13

The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study

Santarsieri, A., Mitchell, E., Pham, M. H., Sanghvi, R., Jablonski, J., Lee-Six, H., Sturgess, K., Brice, P., Menne, T. F., Osborne, W., et al. (2025) · The Lancet Oncology

Lymphoma Diagnosis and TreatmentMultiple and Secondary Primary Cancers

Cited by 12